Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease.

Codrina Mihaela AncutaRodica ChirieacEugen AncuțaOana Tanculescu Sorina Mihaela SolomonAna Maria FătuAdrian DolocaCristina Iordache

Published in: Journal of clinical medicine (2021)

IL-6 inhibition is able to improve periodontal outcomes in patients with RA and concomitant PD, which is essentially related to a dramatic decrease in serum inflammatory mediators.

Keyphrases

rheumatoid arthritis
disease activity
interstitial lung disease
ankylosing spondylitis
oxidative stress
rheumatoid arthritis patients
juvenile idiopathic arthritis
binding protein
skeletal muscle
adipose tissue
glycemic control
systemic sclerosis
drug induced
idiopathic pulmonary fibrosis